Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas.
Ohmachi Y, Yamamoto M, Inaba Y, Makino S, Urai S, Matsumoto R, Bando H, Kanie K, Tsujimoto Y, Motomura Y, Sasaki Y, Oi-Yo Y, Yamamoto N, Suzuki M, Takahashi M, Iguchi G, Kanzawa M, Furukawa J, Shigemura K, Mizobuchi S, Ogawa W, Fukuoka H. Ohmachi Y, et al. Among authors: matsumoto r. Endocrine. 2024 May;84(2):694-703. doi: 10.1007/s12020-023-03681-4. Epub 2024 Jan 11. Endocrine. 2024. PMID: 38206436
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.
Davis-Porada J, George AB, Lam N, Caron DP, Gray JI, Huang J, Hwu J, Wells SB, Matsumoto R, Kubota M, Lee Y, Morrison-Colvin R, Jensen IJ, Ural BB, Shaabani N, Weiskopf D, Grifoni A, Sette A, Szabo PA, Teijaro JR, Sims PA, Farber DL. Davis-Porada J, et al. Among authors: matsumoto r. Immunity. 2024 Oct 29:S1074-7613(24)00483-7. doi: 10.1016/j.immuni.2024.10.003. Online ahead of print. Immunity. 2024. PMID: 39510068
Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin.
Ishikawa G, Matsushita Y, Kitagawa Y, Uchiyama A, Oishi Y, Tanaka H, Watanabe S, Suzuki E, Watanabe S, Watanabe K, Watanabe H, Tamura K, Motoyama D, Matsumoto R, Ito T, Nagata M, Unno T, Furuse H, Mizuno T, Otsuka A. Ishikawa G, et al. Among authors: matsumoto r. Cancer Diagn Progn. 2024 Nov 3;4(6):783-788. doi: 10.21873/cdp.10396. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502620 Free PMC article.
1,198 results